Gut barrier integrity and inflammatory tone

Gut barrier integrity refers to the physical and functional ability of the intestinal mucosa to prevent the translocation of harmful substances, such as pathogens and endotoxins, while allowing nutrient absorption (Vancamelbeke & Vermeire, 2017, Therapeutic Advances in Gastroenterology). This barrier is maintained by a complex interplay of the mucus layer, epithelial cells, and tight junction proteins like claudins and occludins. Inflammatory tone describes the baseline level of immune activation, which often increases when the gut barrier is compromised, leading to metabolic endotoxemia (Cani et al., 2007, Diabetes). This chronic low-grade inflammation is a significant contributor to the development of systemic diseases, including metabolic syndrome, type 2 diabetes, and nonalcoholic fatty liver disease (Chelakkot et al., 2018, Experimental & Molecular Medicine). Therapeutic strategies focus on strengthening the barrier through zonulin antagonists like larazotide or promoting mucosal repair with GLP-2 analogs like teduglutide (Jeppesen, 2012, Journal of Parenteral and Enteral Nutrition). Monitoring efficacy often involves measuring biomarkers such as serum zonulin, lipopolysaccharide-binding protein (LBP), and intestinal fatty acid-binding protein (I-FABP) (Groschwitz & Hogan, 2009, Journal of Allergy and Clinical Immunology).

Other names

Intestinal permeabilityLeaky gutMetabolic endotoxemiaGut-immune axisIntestinal barrier function

Pharmacological intervention aims to restore the intestinal physical barrier by inhibiting zonulin-mediated tight junction disassembly or by stimulating the GLP-2 receptor to enhance mucosal growth and reduce paracellular permeability.